Staining composition for staining an ophthalmic membrane

Details Staining composition for staining an ophthalmic membrane Staining composition for staining an ophthalmic membrane

2005-12-06

2010-06-08

Krass, Frederick (Department: 1612)

Drug, bio-affecting and body treating compositions

Identification or warning feature

Color or color change feature

C514S656000, C514S912000

Reexamination Certificate

active

07731941

ABSTRACT:
A staining composition for staining an ophthalmic membrane when performing the ophthalmic membrane removal, wherein the staining composition comprises a Brilliant Blue G (BBG) derivative as a primary component.

REFERENCES:
patent: 5132439 (1992-07-01), Schultz et al.
patent: 6057160 (2000-05-01), Silber et al.
patent: 6367480 (2002-04-01), Coroneo
patent: 6372449 (2002-04-01), Coroneo et al.
patent: 2006/0140863 (2006-06-01), Meinert et al.
patent: 2004/035091 (2004-04-01), None
patent: 2004/035091 (2004-04-01), None
patent: WO-2004/035091 (2004-04-01), None
Scott E. Burk, ND, PHD, et. al.; “Indocyanine Green—assisted Peeling of the Retinal Internal Limiting Membrane”; Ophthalmology, vol. 107, No. 11, Nov. 2000; pp. 2010-2014 (4 pages).
Alvin K. H. Kwok, MD, FRCS, et. al.; “Indocyanine Green—Assisted Internal Limiting Membrane Removal in Epiretinal Membrane Surgery: a Clinical and Histologic Study”; American Journal of Ophthalmology, vol. 138, No. 2, pp. 194-199. (6 pages).
Vijay K. Dada, MBBS, MS; et al.; “Anterior capsule staining for capsulorhexis in cases of white cataract—Comparative clinical study”; Journal of Cataract and Refractive Surgery, vol. 30, pp. 326-333 (Feb. 2004). (8 pages).
Masayuki Horiguchi, MD, et al.; “Staining of the Lens Capsule for Circular Continuous Capsulorrhexis in Eyes With White Cataract”; Archives of Ophthalmology, vol. 116; pp. 535-537 (Apr. 1998) (3 pages).
Notification of the First Office Action issued May 22, 2009, by The Patent Office of the People's Republic of China, in China Patent Application No. 2005800416779, with English translation (9 pages).
Chi Zhang, et al., “Determination of Protein and Amino Acid Content in Premna”; Journal of Hubei University for Nationalities (Natural Science Edition), 21(1), Mar. 30, 2003; pp. 68-70 (cited in the First Office Action dated May 22, 2009 in China Patent Application No. 2005800416779).
Office Action issued Jun. 9, 2009, by the Canadian Intellectual Property Office, in related-Canadian Patent Application No. 2,590,388 (3 pages) (Please note: The reference, PCT WO 2004/035091, published Apr. 29, 2004, was previously submitted to the USPTO in the IDS filed with the original Application on Jun. 6, 2007.).
EPO Communication of Notice of Opposition filed, issued Feb. 2, 2010, in related Europen Patent Application No. 05814729.9 (2 pages).
EPO Communication of a Notice of Opposition issued Jan. 22, 2010, by the European Patent Office, in related European Patent Application No. 05814729.9, together with the Notice of Opposition filed by Fluoron GmbH, and the English translation of the Notice of Opposition (14 pages).
Tal, Moshe, et al., “Why Does Coomassie Brilliant Blue R Interact Differently with Different Proteins?”; The Journal of Biological Chemistry, ASBMB, vol. 260, No. 18, (Aug. 25, 1980); pp. 9976-9980.
Smejkal, Gary B., “The Coomassie chronicles: past, present and future perspectives in polyacrylamide gel staining”; Future Drugs Ltd. (2004); Expert Rev. Proteoinics 1(4), (2004); ISSN 1478-9450; pp. 381-386.
Diezel, W., et al., “An Improved Procedure for Protein Staining in Polyacrylamide Gels with a New Type of Coomassie Brilliant Blue”; Analytical Biochemistry 48 (1972); pp. 617-620.
Russell, Stephen R., et al., “Distribution of Glycoconjugates in the Human Retinal Internal Limiting Membrane”; Investigative Ophthalmology & Visual Science, vol. 32, No. 7, Jun. 1991; pp. 1986-1995.
Duhamel RC., Abstract of “Differential staining of collagens and non-collagens with Coomassie Brilliant Blue G and R.”; Coll Relat Res. 1983; PubMed, U.S. National Library of Medicine, National Institutes of Health (1 page).

Affiliated with

Also associated with

Rating

Staining composition for staining an ophthalmic membrane does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Staining composition for staining an ophthalmic membrane, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Staining composition for staining an ophthalmic membrane will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4214378